Genetic basis of thoracic aortic aneurysms and dissections: Potential relevance to abdominal aortic aneurysms

Annals of the New York Academy of Sciences

Volumn 1085, Issue , 2006, Pages 242-255

  Pannu, Hariyadarshi ^a   Avidan, Nili ^a   Tran Fadulu, Van ^a   Milewicz, Dianna M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Aneurysms; Aorta; Aortic disease; Dissections; FBN1; MYH11; TGFBR1; TGFBR2; Transforming growth factor

Indexed keywords

CONTRACTILE PROTEIN; MYOSIN HEAVY CHAIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ABDOMINAL AORTA ANEURYSM; AORTA DISSECTING ANEURYSM; AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR SYMPTOM; CHROMOSOME 11Q; CHROMOSOME 16P; CHROMOSOME 3P; CHROMOSOME 5Q; CONFERENCE PAPER; DISEASE COURSE; FAMILIAL DISEASE; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; HUMAN; NONHUMAN; ONSET AGE; PATENT DUCTUS ARTERIOSUS; PENETRANCE; PHENOTYPE; SMOOTH MUSCLE FIBER; THORACIC AORTA ANEURYSM; ARTICLE; CLASSIFICATION; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; MUTATION; PATHOLOGY; SIGNAL TRANSDUCTION; SYNDROME;

AORTIC ANEURYSM, ABDOMINAL; AORTIC ANEURYSM, THORACIC; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MUTATION; SIGNAL TRANSDUCTION; SYNDROME;

EID: 34249709962     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1383.024     Document Type: Conference Paper

References (68)

1. LILIENFELD, D.E., P.D. GUNDERSON, J.M. SPRAFKA & C. VARGAS. 1987. Epidemiology of aortic aneurysms: I. Mortality trends in the United States, 1951 to 1981. Arteriosclerosis 7: 637-643.
2. LINDSAY, J., JR. 1997. Diagnosis and treatment of diseases of the aorta. Curr. Probl. Cardiol. 22: 485-542.
3. PLEUMEEKERS, H.J., A.W. HOES, D.E. VAN DER, et al.1995. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am. J. Epidemiol. 142: 1291-1299.
4. THOMPSON, R.W., D.R. HOLMES, R.A. MERTENS, et al. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96: 318-326.
5. PYO, R., J.K. LEE, J.M. SHIPLEY, et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105: 1641-1649.
6. BICKERSTAFF, L.K., P.C. PAIROLERO, L.H. HOLLIER, et al. 1982. Thoracic aortic aneurysms: a population-based study. Surgery 92: 1103-1108.
7. ERDHEIM, J. 1930. Medionecrosis aortae idiopathica cystica. Virchows Arch. Path. Anat. 276: 187-229.
8. TILSON, M.D. & M.R. SEASHORE. 1984. Fifty families with abdominal aortic aneurysms in two or more first-order relatives. Am. J. Surg. 147: 551-553.
9. WEBSTER, M.W., P.L. ST. JEAN, D.L. STEED, et al. 1991. Abdominal aortic aneurysm: results of a family study. J. Vasc. Surg. 13: 366-372.
10. COLLIN, J. 1996. The oxford screening program for aortic aneurysm and screening first-order male siblings of probands with abdominal aortic aneurysm. Ann. N. Y. Acad. Sci. 800: 36-43.
11. VERLOES, A., N. SAKALIHASAN, R. LIMET & L. KOULISCHER. 1996. Genetic aspects of abdominal aortic aneurysm. Ann. N. Y. Acad. Sci. 800: 44-55.
12. NORRGARD, O., O. RAIS & K.A. ANGQUIST. 1984. Familial occurrence of abdominal aortic aneurysms. Surgery 95: 650-656.
13. MAJUMDER, P.P., P.L. ST. JEAN, R.E. FERRELL, et al. 1991. On the inheritance of abdominal aortic aneurysm. Am. J. Hum. Genet. 48: 164-170.
14. SHIBAMURA, H., J.M. OLSON, C. VAN VLIJMEN-VAN KEULEN, et al. 2004. Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 109: 2103-2108.
15. FINKBOHNER, R., D. JOHNSTON, E.S. CRAWFORD, et al. 1995. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation 91: 728-733.
16. SILVERMAN, D.I., K.J. BURTON, J. GRAY, et al. 1995. Life expectancy in the Marfan syndrome. Am. J. Cardiol. 75: 157-160.
17. VAN KARNEBEEK, C.D., M.S. NAEFF, B.J. MULDER, et al. 2001. Natural history of cardiovascular manifestations in Marfan syndrome. Arch. Dis. Child 84: 129-137.
18. LEE, B., M. GODFREY, E. VITALE, et al. 1991. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352: 330-334.
19. CORSON, G.M., S.C. CHALBERG, H.C. DIETZ, et al. 1993. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics 17: 476-484.
20. PEREIRA, L., M. D'ALESSIO, F. RAMIREZ, et al. 1993. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum. Mol. Genet. 2: 961-968.
21. MILEWICZ, D.M., J. GROSSFIELD, S.N. CAO, et al. 1995. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J. Clin. Invest. 95: 2373-2378.
22. MILEWICZ, D.M., K. MICHAEL, N. FISHER, et al. 1996. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 94: 2708-2711.
23. FRANCKE, U., M.A. BERG, K. TYNAN, et al. 1995. A Gly1127Ser mutation in An Egf-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am. J. Hum. Genet. 56: 1287-1296.
24. ADES, L.C., D. SREETHARAN, E. ONIKUL, et al. 2002. Segregation of a novel FBN1 gene mutation, G1796E, with kyphoscoliosis and radiographic evidence of vertebral dysplasia in three generations. Am. J. Med. Genet 109: 261-270.
25. FAIVRE, L., R.J. GORLIN, M.K. WIRTZ, et al. 2003. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med. Genet. 40: 34-36.
26. KATZKE, S., P. BOOMS, F. TIECKE, et al. 2002. TGGE screening of the entire FBN1 coding sequence in 126 individuals with Marfan syndrome and related fibrillinopathies. Hum. Mutat. 20: 197-208.
27. HOLLISTER, D.W., M. GODFREY, L.Y. SAKAI & R.E. PYERITZ. 1990. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N. Engl. J. Med. 323: 152-159.
28. MILEWICZ, D.M., R.E. PYERITZ, E.S. CRAWFORD & P.H. BYERS. 1992. Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J. Clin. Invest. 89: 79-86.
29. AOYAMA, T., U. FRANCKE, H.C. DIETZ & H. FURTHMAYR. 1994. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J. Clin. Invest. 94: 130-137.
30. NEPTUNE, E.R., P.A. FRISCHMEYER, D.E. ARKING, et al. 2003. Dysregulation of TGFbeta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33: 407-411.
31. NG, C.M., A. CHENG, L.A. MYERS, et al. 2004. TGF beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J. Clin. Invest. 114: 1586-1592.
32. HABASHI, J.P., D.P. JUDGE, T.M. HOLM, et al. 2006. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117-121.
33. COLLOD, G., M.C. BABRON, G. JONDEAU, et al. 1994. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat. Genet. 8: 264-268.
34. BOILEAU, C., G. JONDEAU, M.C. BABRON, et al. 1993. Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am. J. Hum. Genet. 53: 46-54.
35. DIETZ, H., U. FRANCKE, H. FURTHMAYR, et al. 1995. The question of heterogeneity in Marfan syndrome. Nat. Genet. 9: 228-231.
36. MIZUGUCHI, T., G. COLLOD-BEROUD, T. AKIYAMA, et al. 2004. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 36: 855-860.
37. LOEYS, B.L., J. CHEN, E.R. NEPTUNE, et al. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37: 275-281.
38. DENTON, C.P., B. ZHENG, L.A. EVANS, et al. 2003. Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. J. Biol. Chem. 278: 25109-25119.
39. DENTON, C.P., G.E. LINDAHL, K. KHAN, et al. 2005. Activation of 78II transforming growth factor-{beta} receptor (T{beta}RII{Delta}k). J. Biol. Chem. 280: 16053-16065.
40. NICOD, P., C. BLOOR, M. GODFREY, et al. 1989. Familial aortic dissecting aneurysm. J. Am. Coll. Cardiol. 13: 811-819.
41. BIDDINGER, A., M. ROCKLIN, J. COSELLI & D.M. MILEWICZ. 1997. Familial thoracic aortic dilatations and dissections: a case control study. J. Vasc. Surg. 25: 506-511.
42. COADY, M.A., R.R. DAVIES, M. ROBERTS, et al. 1999. Familial patterns of thoracic aortic aneurysms. Arch. Surg. 134: 361-367.
43. MILEWICZ, D.M., H. CHEN, E.S. PARK, et al. 1998. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am. J. Cardiol. 82: 474-479.
44. HASHAM, S.N., M.C. WILLING, D.C. GUO, et al. 2003. Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107: 3184-3190.
45. GUO, D., S. HASHAM, S.Q. KUANG, et al. 2001. Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103: 2461-2468.
46. KAKKO, S., T. RAISANEN, M. TAMMINEN, et al. 2003. Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5q13-14 in Finnish families. J. Thorac. Cardiovasc. Surg. 126: 106-113.
47. VAUGHAN, C.J., M. CASEY, J. HE, et al. 2001. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 103: 2469-2475.
48. PANNU, H., V. FADULU, J. CHANG, et al. 2005. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112: 513-520.
49. KIM, S.J., Y.H. IM, S.D. MARKOWITZ & Y.J. BANG. 2000. Molecular mechanisms of inactivation of TGFbeta receptors during carcinogenesis. Cytokine Growth Factor Rev. 11: 159-168.
50. VAN KIEN, P.K., J.E. WOLF, F. MATHIEU, et al. 2004. Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity. Eur. J. Hum. Genet. 12: 173-180.
51. GLANCY, D.L., M. WEGMANN & R.W. DHURANDHAR. 2001. Aortic dissection and patent ductus arteriosus in three generations. Am. J. Cardiol. 87: 813-815, A9.
52. ZHU, L., R. VRANCKX, P.K. VAN KIEN, et al. 2006. Mutations inmyosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat. Genet. 38: 343-349.
53. AHMAD, F., J.G. SEIDMAN & C.E. SEIDMAN. 2005. The genetic basis for cardiac remodeling. Annu. Rev. Genomics Hum. Genet. 6: 185-216.
54. TRAN-FADULU, V.T., J. CHEN, D. LEMUTH, et al. 2006. Syndrome of ascending and descending aortic dissections due to novel locus: variable expression in momozygotic twins and evidence for de novo mutations. Am. J. Med. Genet. 140: 1196-1202.
55. AVIDAN, N., V. TRAN-FADULU, J. CHEN, et al. 2006. A novel locus for familial thoracic aortic aneurysms and dissection mapped to 15q24-26 (TAAD3): locus specific phenotypes for familial aortic disease.Submitted.
56. MCKUSICK, V.A. 1972. Association of congenital bicuspid aortic valve and Erdheim's cystic medial necrosis. Lancet 1: 1026-1027.
57. MCKUSICK, V.A., R.B. LOGUE & H.T. BAHSON. 1957. Association of aortic valvular disease and cystic medial necrosis of the ascending aorta. Circulation 16: 188-194.
58. LINDSAY, J., JR. 1988. Coarctation of the aorta, bicuspid aortic valve and abnormal ascending aortic wall. Am. J. Cardiol. 61: 182-184.
59. SCHIEVINK, W.I. & B. MOKRI. 1995. Familial aorto-cervicocephalic arterial dissections and congenitally bicuspid aortic valve. Stroke 26: 1935-1940.
60. KIM, D.H., G. VAN GINHOVEN & D.M. MILEWICZ. 2005. Familial aggregation of both aortic and cerebral aneurysms: evidence for a common genetic basis in a subset of families. Neurosurgery 56: 655-661.
61. HAHN, R.T., M.J. ROMAN, A.H. MOGTADER & R.B. DEVEREUX. 1992. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J. Am. Coll. Cardiol. 19: 283-288.
62. GLICK, B.N. & W.C. ROBERTS. 1994. Congenitally bicuspid aortic valve in multiple family members. Am. J. Cardiol. 73: 400-404.
63. CLEMENTI, M., L. NOTARI, A. BORGHI & R. TENCONI. 1996. Familial congenital bicuspid aortic valve: a disorder of uncertain inheritance. Am. J. Med. Genet. 62: 336-338.
64. HUNTINGTON, K., A.G. HUNTER & K.L. CHAN. 1997. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J. Am. Coll. Cardiol. 30: 1809-1812.
65. ROSENQUIST, T.H. & A.C. BEALL. 1990. Elastogenic cells in the developing cardiovascular system. Smooth muscle, nonmuscle, and cardiac neural crest. Ann. N. Y. Acad. Sci. 588: 106-119.
66. ADES, L.C., K. SULLIVAN, A. BIGGIN, et al. 2006. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am. J. Med. Genet. 140A: 1047-1058.
67. KI, C.S., D.K. JIN, S.H. CHANG, et al. 2005. Identification of a novel TGFBR2 gene mutation in a Korean patient with Loeys-Dietz aortic aneurysm syndrome; no mutation in TGFBR2 gene in 30 patients with classic Marfan's syndrome. Clin. Genet. 68: 561-563.
68. DISABELLA, E., M. GRASSO, N. MARZILIANO, et al. 2006. Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects Eur. J. Hum. Genet. 14: 34-38.